Oregon Health & Science University

I'm Michael Dunne.

From its stately, if slightly dated, campus on the hill to its incredibly modern-looking facility next to the river and the ever-present Sky Tram connecting both, OHSU casts a very impressive image as one enters the city of Portland from the freeway.

And beyond the facilities, the institution boasts both the premier medical university and hospital in the state.

Today on the show, you'll meet the man in charge of this national facility that calls Oregon home and hear about his vision to further expand its hospital's reach and also expand its ability to teach the next generation of healthcare professionals.

That's next on Oregon on the Record.

Today on the show, two sides of the education coin.

On one side, we'll talk with the president of OHSU, which has a long wait list of students who want to further their medical education at this robust institution.

On the other side is a story about further harsh cuts to the budget of Eugene's 4J school district, where declining enrollment is harshly impacting local schools.

And they're really used to prevent mass shootings, to prevent domestic violence shootings or someone who is suicidal.

A recent study by OHSU and PSU found that in the first seven years under the law, since the ERPO law in Oregon went into effect, a little more than 1,000 petitions were filed statewide, and about 80% of those were granted.

It's interesting that year by year, the approval rate of these petitions by judges is relatively low.

flat.

And we're starting to see some of those play out.

There's just a paper at GI ASCO by a group at OHSU where they used an AI tool to predict responsiveness to first-line therapy in pancreatic cancer.

prior to surgery.

You know, we have two kind of chemotherapeutic approaches, and this can help guide that decision-making on the front end.

And again, they were transitioned to sublingual buprenorphine and found a really, I think, clinically meaningful reduction in pain intensity from seven to 3.5 and also saw a small but probably relevant improvement in quality of life.

A little closer to home, this is a case series of eight patients at OHSU from 2019 to 2020.

They, you know, kind of, Quickly summarizing here, patients from 50 to 70 years of age with kind of an array of chronic pain indications.

Most of them didn't have substance use disorder.

That's quite the contraption.

Jace rode with her, and the plan was that I would follow in my own ambulance later to be transferred to OHSU's maternity ward.

At

one point, everyone had left the room and there I sat with my cafeteria pancakes and eggs all by myself.

This had not happened with my first baby.

This had not happened to any of my friends.

This is the picture that Jace sent me from the NICU when I was finally on my way to OHSU in my ambulance.

It was a whirlwind day, and it wasn't until later that afternoon that I was finally reunited with Addie and Jace.

maybe vital signs being monitored while people are receiving psilocybin.

Researcher Todd Korthis and his team at OHSU were interested in learning more about the benefits and drawbacks of using psilocybin in Oregon service centers.

The most important comparison that we were interested in is assessing safety and changes in mental health in the state regulator programs compared with other psychedelic clinical trials that have been conducted.

Korthis explained that one of the big differences with the Oregon program is that it's what he called a wellness model rather than a medical model.